Cristalli Di Storicità 2019
DOI: 10.4000/books.res.2237
|View full text |Cite
|
Sign up to set email alerts
|

Friedrich Hölderlin e la filosofia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…As the first full α7 nAChR agonist, AR-R17779 ( 44 ) features a 1-aza-bicyclo[2.2.2]­octane scaffold and shows reasonable binding affinity ( K i = 92 nM) and selectivity toward α7 nAChRs over α4β2 nAChRs ( K i = 16 μM) . Some derivatives of AR-R17779 ( 44 ) were patented as α7 nAChR agonists; however, there is no available pharmacological data . The radiolabeling of one compound in this series with [ 11 C]­phosgene resulted in radioligand [ 11 C] 2 ( 45 ) .…”
Section: Pet Tracers Targeting Nicotinic Acetylcholine Receptors (Nac...mentioning
confidence: 99%
See 1 more Smart Citation
“…As the first full α7 nAChR agonist, AR-R17779 ( 44 ) features a 1-aza-bicyclo[2.2.2]­octane scaffold and shows reasonable binding affinity ( K i = 92 nM) and selectivity toward α7 nAChRs over α4β2 nAChRs ( K i = 16 μM) . Some derivatives of AR-R17779 ( 44 ) were patented as α7 nAChR agonists; however, there is no available pharmacological data . The radiolabeling of one compound in this series with [ 11 C]­phosgene resulted in radioligand [ 11 C] 2 ( 45 ) .…”
Section: Pet Tracers Targeting Nicotinic Acetylcholine Receptors (Nac...mentioning
confidence: 99%
“… 132 Some derivatives of AR-R17779 ( 44 ) were patented as α7 nAChR agonists; however, there is no available pharmacological data. 133 The radiolabeling of one compound in this series with [ 11 C]phosgene resulted in radioligand [ 11 C] 2 ( 45 ). 134 Ex vivo biodistribution studies of [ 11 C] 2 ( 45 ) in rats demonstrated reasonable brain uptake with 0.8–1.2%ID/g among various brain regions.…”
Section: Pet Tracers Targeting Nicotinic Acetylcholine Receptors (Nac...mentioning
confidence: 99%